A.
Szkola
a,
E. M.
Linares
a,
S.
Worbs
b,
B. G.
Dorner
b,
R.
Dietrich
c,
E.
Märtlbauer
c,
R.
Niessner
a and
M.
Seidel
*a
aChair for Analytical Chemistry & Institute of Hydrochemistry, TU München, Marchioninistrasse 17, 81377 Munich, Germany. E-mail: michael.seidel@ch.tum.de; Fax: +49 (89) 2180-78255; Tel: +49 (89) 2180-78238
bCentre for Biological Threats and Special Pathogens, Biological Toxins, Robert Koch-Institut, Nordufer 20, 13353 Berlin, Germany
cChair of Hygiene and Technology of Milk, LMU München, Schönleutnerstraße 8/219, 85764 Oberschleißheim, Germany
First published on 5th September 2014
Simultaneous detection of small and large molecules on microarray immunoassays is a challenge that limits some applications in multiplex analysis. This is the case for biosecurity, where fast, cheap and reliable simultaneous detection of proteotoxins and small toxins is needed. Two highly relevant proteotoxins, ricin (60 kDa) and bacterial toxin staphylococcal enterotoxin B (SEB, 30 kDa) and the small phycotoxin saxitoxin (STX, 0.3 kDa) are potential biological warfare agents and require an analytical tool for simultaneous detection. Proteotoxins are successfully detected by sandwich immunoassays, whereas competitive immunoassays are more suitable for small toxins (<1 kDa). Based on this need, this work provides a novel and efficient solution based on anti-idiotypic antibodies for small molecules to combine both assay principles on one microarray. The biotoxin measurements are performed on a flow-through chemiluminescence microarray platform MCR3 in 18 minutes. The chemiluminescence signal was amplified by using a poly-horseradish peroxidase complex (polyHRP), resulting in low detection limits: 2.9 ± 3.1 μg L−1 for ricin, 0.1 ± 0.1 μg L−1 for SEB and 2.3 ± 1.7 μg L−1 for STX. The developed multiplex system for the three biotoxins is completely novel, relevant in the context of biosecurity and establishes the basis for research on anti-idiotypic antibodies for microarray immunoassays.
The use of biotoxins as biological weapon displays a permanent risk for humans.15 The described biotoxins are relatively easy to spread, causing moderate to high mortality. Due to their characteristics, these toxins are probable candidates for a warfare use and therefore need to be verified in case of terrorist attack suspicion. This potential risk leads to a demand on the simultaneous diagnosis of the biotoxins by a fast, cheap and reliable assay. Different techniques have been described to detect those toxins,3,16 including chromatography,17 spectrophotometry,18,19 mass spectrometry,20,21 electrochemistry,22 as well as assays addressing functional activity.23 While a wide range of methods is used, many assays rely on immunological detection of target molecules due to the high specificity and sensitivity.31 Microarray immunoassays (MIAs) in particular have gained attention, as they benefit of the capability to test a wide variety of analytes in a single assay, reducing time of analysis and costs.32 MIA for biotoxins is a promising tool for the identification and detection of an eventual contamination and different approaches have been described in the literature.33–35 An overview of recent detection limits for biotoxins in microarrays is given in the Table 1.
Biotoxins | Application | Limit of detection (μg L−1) | Type of detection | Reference |
---|---|---|---|---|
Ricin | Biosecurity | 0.1 | Antibody/fluorescence | 24 |
SEB | 0.01 | |||
Ricin | Food safety | 0.5 | Antibody/fluorescence | 25 |
SEB | 0.5 | |||
Ricin | Protein screening | 15 | Aptamer/fluorescence | 26 |
Ricin | Biosecurity | 80 | Carbohydrate/chemiluminescence | 27 |
SEB | Proof of principle for microarray development | 3.10–6 | Antibody/electrochemistry | 28 |
STX | Food safety | 0.4 | Antibody/chemiluminescence | 29 |
STX | Food safety | 0.82 | Antibody/surface plasmon resonance | 30 |
Although some microarrays have been successfully developed, a few challenges still need to be faced according to the broad diversity of samples and particularities of each biotoxin. In order to overcome these problems, different approaches have been described combining different assay principles on the microarray. Hartmann et al.36 described a novel assay format that combines competitive and direct immunoassay principles into one system to overcome dilution sample problems of proteins. Molecules present in high concentrations as well as those occurring at low concentrations could be quantified within the same assay. A greater challenge is the wide range of molecular weight. Small molecules with less than 1000 Da in molecular weight are not considered amenable to sandwich immunoassays due to their difficulty of simultaneous recognition by two antibodies.37 In this case, other arrangements can be used, including competitive assays. Parro et al.38 and Fernández-Calvo et al.39 described the development of protein microarray technologies for automatic in situ detection and identification combining sandwich and competitive immunoassays. The assay was developed to analyze liquid and solid samples from extraterrestrial origin, ranging from small molecules and proteins to whole cells and spores. Although the direct immobilization of analytes on the microarray for the competitive assay was successfully performed, this is not always the case. There are small molecules whose structure does not have enough functional groups for immobilization or are not available in the required amounts.40 In this case, the immobilization may affect the antibody recognition, the regenerability of the microarray or does not provide concentrated spots, as already described for STX.29 Additionally, the direct immobilization of molecules on the microarray may require previous coupling to other larger molecules (e.g. albumin) or different chemical functionalities on the microarray surface, which increases the work and cost of production.
Based on this challenge, this work describes the development of a microarray for ricin, SEB and STX detection, combining sandwich and indirect competitive immunoassays in one platform. The combination of both methods is possible through the use of anti-idiotypic antibodies for small molecules. These antibodies are immunoglobulins, whose paratope mimics the structure of an antigen and recognize the epitopes of the antibody produced for the antigen.41 It represents a powerful alternative for direct immobilization of small molecules, in this case STX, on the microarray. The proteotoxins, ricin and SEB, are detected using sandwich based immunoassay, where labeled antibodies bind to the antigen and the antibody–antigen pairs are captured by the immobilized antibodies. For STX detection, a competition between its labeled antibodies and the immobilized anti-idiotypic antibodies take place on the chip. Thus, it is produced a microarray containing anti-idiotypic antibodies for STX and conventional antibodies for ricin and SEB. This strategy avoids the need of analyte coupling to large molecules or different surface chemistry for immobilizing antibodies and analyte on the same microarray surface. The microarray is placed in an automated system, the Munich Chip Reader (MCR3), which allows precise and fast on-site analysis. For the first time, MIA is capable to detect proteotoxins and small toxins, simultaneously. The microarray can be used as a tool for monitoring biotoxins in samples as a preventive protection of the population against natural or deliberate contaminations. Moreover, this technology shows the potential of anti-idiotypic antibodies for the simultaneous detection of small and large molecules on the same microarray.
Mouse monoclonal antibody (mAb) production against ricin (R109, R18, R21) and SEB (S1001, S419) was described elsewhere.31 Clone S3849 against SEB was produced similarly. Highly purified agglutinin and ricin were produced as described.42 Anti-idiotypic antibodies from mouse mAb 1F8, anti-STX from mouse mAb 7H11 and biotinylated anti-STX from mouse mAb 7H11 were obtained from the Chair of Hygiene and Technology of Milk (LMU Munich, Germany). Anti-idiotypic antibody production and antibody biotinylation are described in more details in the ESI (S1†). HRP-labeled streptavidin was purchased from Axxora Germany GmbH (Lörrach, Germany). Horseradish peroxidase (HRP) was purchased from Roche Diagnostics GmbH (Mannheim, Germany). Saxitoxin (STX) was obtained from Institute of Agri-Food and Land Use (Belfast, Ireland). Staphylococcus enterotoxin B (SEB) was purchased from Diavita GmbH (Heidelberg, Germany). Poly(horseradish peroxidase)–streptavidin (SA–PolyHRP40) was obtained from Senova GmbH (Jena, Germany).
Prior to the detection, the biotinylated antibodies and the biotoxins are incubated together to promote the interaction between the respective antigen–antibody pairs. This step is especially important for the competitive assay for STX detection.
On the microarray, the pairs of antibody–biotoxin bind to the respective capture antibodies for ricin and SEB, producing a sandwich. In contrast, the detection of STX occurs through a competition between the free STX molecules and the immobilized anti-idiotypic antibodies to the biotinylated anti-STX antibodies. The detection signal is provided by enzyme catalyzed chemiluminescence reaction with luminol and hydrogen peroxide, using peroxidase–streptavidin conjugates. The signal for ricin and SEB are directly proportional to the biotoxin concentrations. For STX, the chemiluminescence intensity is inversely proportional to the concentration of the antigen. The pre-incubation of the biotinylated antibodies with the biotoxins is performed by the injection of the solutions into the loop of the MCR3 system (Fig. 1b). The solution is then automatically driven to the microarray surface, where the reactions take place and the signal is registered. The spots on the microarray are identified by their location on the recorded image. The antibodies are spotted on a defined location and order, which allows the fast recognition of the correspondent system.
To enhance the assay sensitivity, the conventional label based on enzyme horseradish peroxidase–streptavidin (SA–HRP) conjugates was replaced by poly(horseradish peroxidase)–streptavidin (SA–PolyHRP40) conjugates. SA–PolyHRP40 is a supramolecular complex composed of five identical covalent HRP homopolymer blocks covalently coupled to streptavidin molecules. For the SA–PolyHRP40, there is an average of 200 monomer HRP molecules per complex unit.46 The comparison of both labels was performed using a sandwich ELISA immunoassay with TMB substrate, monoclonal capture antibody R109 and monoclonal detection antibody R18. The calibration curves for SA–HRP and SA–PolyHRP40 (available at the ESI, S2†) were obtained in the range of 0 to 1000 μg L−1 of agglutinin. The SA–PolyHRP40 curve showed higher sensitivity with a working range saturating at 100 μg L−1, where the SA–HRP curve only started its working range with 10 times lower absorbance. PolyHRP40 conjugates quantitatively delivered a large number of signal-generating enzyme molecules per one bound analyte molecule, resulting in a considerable signal enhancement. As a result, the assay using SA–PolyHRP40 produces higher sensitivity and therefore it was chosen for the next optimizations. For all further measurements ricin has been used instead of agglutinin, which is recognized by the same set of antibodies with high affinity.47
To combine sandwich and competitive immunoassay principles in the flow system, it is important to meet the requirements of the individual assays. The competitive immunoassay requires the pre-incubation of the antibody and the antigen prior to the detection with parallel addition on the microarray. For the sandwich assay, the pre-incubation is not necessary, but it can also be favorable for the detection. In order to investigate the effects of the sequential or parallel addition on the assay performance, four conditions were compared for ricin: (I) sequential addition of reactants (ricin and biotinylated detection antibody) at 1 μL s−1 with 10 s of interaction time (duration: 1 h 15 min), (II) parallel addition in continuous flow at 1 μL s−1 (duration: 26 min), (III) parallel addition with pre-incubation step of the detection antibody and the ricin for 1 min in the MCR3 loop, injecting 50 μL of sample at 1 μL s−1 with 20 s of incubation time (duration: 34 min) and (IV) parallel addition with pre-incubation step, injecting 5 μL of sample at 1 μL s−1 with 10 s of incubation time (duration: 1 h 15 min). The assay was tested with two different capture antibodies, R109 and R21, and the biotinylated mAb R18 as the detection antibody. The results (see ESI, S3†) indicated that the parallel addition produces faster results with higher chemiluminescence signal for all conditions in comparison to the sequential addition. The evaluation of the three conditions using parallel addition (II–IV) indicated better performance with the use of stopped-flow principle (III and IV) as an approximation to a stationary system. In this case, a defined volume is pumped into the chip and remains there for a certain time. The method (IV) results in higher CL signal (8421 a.u. for R109 and 7827 a.u. for R21) than the method (III) with 2988 a.u. for R109 and 3756 a.u. for R21, indicating that a lower unit volume in a shorter time interaction leads to higher signals. Although the incubation time for the method IV is half of the method III, the additional interaction time for the program IV was 41 minutes. This means that the ricin molecules had more time to come in contact with the immobilized antibodies and interact with them, justifying the higher CL-signal intensity. It is also observed that the monoclonal R109 antibody produces higher CL signal in comparison to the R21 antibody. The results showed that the use of parallel addition with stopped flow principle is favorable to enhance the assay sensitivity for the sandwich assay and it indicates the promising combination with the competitive assay in the multiplex system.
The influence of the sample volume, flow rate and interaction time on the CL signal was also investigated and the results are described in the ESI (S4†). The injected volume on the microarray was varied from 5 to 50 μL and the CL signal was compared. The signals for 5 μL (57681 a.u. for R109 and 54483 a.u. for R21) and 50 μL (49912 a.u. for R109 and 48150 a.u. for R21) showed a maximum decrease in the CL signal intensity of 13.5%. Nevertheless, the assay time is more than two times faster for 50 μL than for 5 μL. Therefore, the volume of 50 μL was chosen. The flow rate optimization showed that 10 μL s−1 was the best compromise between assay time and CL signal, reducing even more the analysis time to 18 min. Table 2 summarizes the final optimized parameters, indicating pre-incubation of biotoxins and antibodies for 1 min in the loop, injection of 50 μL units of the mixture by a stopped-flow principle at a flow rate of 10 μL s−1 with interaction times of 10 s.
Parameters | Optimized values |
---|---|
Label | Poly(horseradish peroxidase)–streptavidin |
Time of pre-incubation | 1 min |
Injected volume | 50 μL |
Flow rate | 10 μL s−1 |
Interaction time | 10 s |
Total duration | 18 min |
![]() | ||
Fig. 2 Calibration curves. Calibration curves separately obtained for ricin, SEB and STX. Different combination of antibodies were used for ricin and SEB. |
Staphylococcal enterotoxin B is similarly to ricin a high molecular weight toxin and is detected in a heterogeneous sandwich ELISA. Therefore, the measurement program optimized for ricin was also used for the SEB detection. The calibration curve was produced by varying the concentration from 0 to 1000 μg L−1. For the detection of SEB three monoclonal antibodies were used: S3849, S1001 and S419. These antibodies were tested as capture and detection antibodies, resulting in 6 combinations in a sandwich format. Fig. 2b shows three combinations that yielded the most sensitive calibration curves. The antibody pair S3849 and S419 provided the highest CL signals. However, the sensitivity of this antibody pair is lower because the midpoint is 108.2 μg L−1 and the working area is from 31.2 to 375.5 μg L−1 compared to the other two antibody pairs, which are shifted to higher levels. The other two pairs S1001 with S419 and S419 with S1001 showed work areas as well as the midpoint in the same order. However, the antibody pair S1001with S419 has a higher CL signal intensity by a factor of 2 for each calibration point and also a lower detection limit, 0.1 μg L−1. Thus, the antibody pair S1001 with S419 was chosen for the following multiplex measurements.
STX detection was performed with anti-idiotypic antibodies in an indirect competitive ELISA format. The antibodies were immobilized at 0.5 g L−1 on the glass surface of the chip. The saxitoxin calibration curve was obtained for the concentration range of 0 to 500 μg L−1, using the same optimized conditions for ricin. Fig. 2c shows the calibration curve with the midpoint at 13.2 μg L−1 and the detection limit at 1.4 μg L−1. The specified operating range is between 3.2 and 54.1 μg L−1. The use of anti-idiotypic antibodies is the first step for the successful combination of the two assay principles into one antibody microarray platform. It also has the advantage of using the same conditions for the immobilization, incubation and blocking steps.
The calibration data of the multiplexed measurements are listed in Table 3. To compare the three calibration curves, the coefficient of variation (CV) was calculated from the midpoint of the three multiplex calibration curves. The variation coefficient was 13.9% for ricin, 9.3% for SEB and 28.0% for STX. The detection limit obtained for STX is similar to the LOD described by Szkola et al.29 in an indirect microarray. This indicates the successful adaptation to the competitive assay.
Toxin | IC50 (μg L−1) | WR (20–80%) (μg L−1) | LOD (μg L−1) | CV (%) |
---|---|---|---|---|
Ricin | 93.7 ± 13.1 | 23.8 ± 2.7–301.9 ± 43.8 | 2.9 ± 3.1 | 13.9 |
SEB | 8.7 ± 0.8 | 1.7 ± 0.4–48.6 ± 15.2 | 0.1 ± 0.1 | 9.3 |
STX | 10.1 ± 2.8 | 2.6 ± 1.5–37.2 ± 3.3 | 2.3 ± 1.7 | 28.0 |
Furthermore, the LOD for ricin and SEB are as low as the available microarrays for this biotoxins, as shown in the Table 1.
Reproducibility measurements were performed using a new microarray chip per analysis and different biotoxin concentrations: ricin 500 μg L−1, SEB 100 μg L−1 and saxitoxin 10 μg L−1. The results of the four measurements indicated stable CL signals with low standard deviation: 1.8% for ricin, 4.1% for SEB and 3.5% for STX. These results prove that a parallel measurement of biotoxins with different molecular weight is possible.
For the determination of recovery rates (Table 4), the biotoxins were first calibrated simultaneously, followed by sample measurement. The samples were plotted together with the calibration curve (Fig. 3). The CL signals of the sample agree with the calibration curves. Table 3 lists the values of the recovery rates measured. An average recovery rate for ricin was 11.1 μg L−1 for the sample with a concentration of 10 μg L−1 and 100.9 μg L−1 for the sample with 100 μg L−1. Comparable good recoveries were obtained for SEB with 11.1 μg L−1 and 92.5 μg L−1 and for STX with 10.2 μg L−1 and 94.5 μg L−1, even for the concentrations out of the working range between 20 and 80%. The spiked sample of water is an example of matrix, which can assume different types in real analysis. Water and food are cited as the most probable, but other matrices can also be analyzed, such as contaminated soil. Real samples may bring some difficulties, which prevent the directly application in the MCR3. Water samples, for example, must be filtered in order to avoid blocking of the microfluidic channel and solid samples should be digested and brought to a liquid form to inject in the machine. Although the antibodies are highly specific for the toxins, cross-reactions may also be considered.
Amount | Recovery | |||||
---|---|---|---|---|---|---|
Ricin | SEB | STX | ||||
(μg L−1) | (μg L−1) | (%) | (μg L−1) | (%) | (μg L−1) | (%) |
10 | 10.7 | 106.6 | 10.6 | 106.5 | 9.8 | 98.6 |
10 | 11.5 | 115.3 | 11.6 | 116.3 | 10.6 | 105.9 |
Average | 11.1 ± 0.6 | 110.9 ± 6.2 | 11.1 ± 0.7 | 111.4 ± 6.9 | 10.2 ± 0.5 | 102.3 ± 5.1 |
100 | 87.6 | 87.6 | 113.7 | 113.7 | 97.0 | 97.0 |
100 | 114.1 | 114.1 | 71.4 | 71.4 | 92.5 | 92.5 |
Average | 100.9 ± 18.6 | 100.9 ± 18.6 | 92.5 ± 29.9 | 92.5 ± 29.9 | 94.5 ± 3.2 | 94.5 ± 3.2 |
Footnote |
† Electronic supplementary information (ESI) available: ESI S1 Experimental details; S2 comparison between horseradish peroxidase–streptavidin (SA–HRP) and poly(horseradish peroxidase)–streptavidin (SA–PolyHRP40); S3 influence of the sequential and parallel addition of reactants; S4 influence of the flow rate and interaction time on the CL signal. See DOI: 10.1039/c4an00345d |
This journal is © The Royal Society of Chemistry 2014 |